Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
January 10 2024 - 8:00AM
Business Wire
Bone Biologics Corporation (“Bone Biologics” or the
“Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic
products for spine fusion markets, today announced that it has
received notice from The NASDAQ Stock Market LLC (Nasdaq) informing
the Company that it has regained compliance with the minimum bid
price requirement under Nasdaq Listing Rule 5550(a)(2) for
continued listing on The Nasdaq Capital Market. Bone Biologics is
now in compliance with all applicable listing standards and its
common stock will continue to be listed on The Nasdaq Capital
Market, but will remain under Nasdaq’s discretionary panel monitor
until June 28, 2024.
Bone Biologics was notified by Nasdaq on September 27, 2023 that
it was not in compliance with the minimum bid price rule because
its common stock failed to meet the closing bid price of $1.00 or
more for 30 consecutive business days. In order to regain
compliance with the Rule, the Company was required to maintain a
minimum closing bid price of $1.00 or more for at least 10
consecutive trading days. This requirement was met on January 4,
2024, the 10th consecutive trading day when the closing bid price
of the Company's common stock was over $1.00.
About Bone Biologics
Bone Biologics was founded to pursue regenerative medicine for
bone. The Company is undertaking work with select strategic
partners that builds on the preclinical research of the Nell-1
protein. Bone Biologics is focusing development efforts for its
bone graft substitute product on bone regeneration in spinal fusion
procedures, while additionally having rights to trauma and
osteoporosis applications. For more information, please visit
www.bonebiologics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240110540852/en/
LHA Investor Relations Kim Sutton Golodetz 212-838-3777
kgolodetz@lhai.com
Bone Biologics (NASDAQ:BBLG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bone Biologics (NASDAQ:BBLG)
Historical Stock Chart
From Oct 2023 to Oct 2024